Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines

Fascaplysin sensitizes cells to TRAIL-induced apoptosis through upregulating DR5 expression

(2013) Feng Wang et al.   CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY

Multidisciplinary Management of Small Cell Lung Cancer

(2013) Sarah B. Goldberg et al.   Surgical Oncology Clinics of North America

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity

(2013) Julie K. Horton et al.   Frontiers in Oncology

Redox modulation of the DNA damage response

(2012) Fanny Caputo et al.   BIOCHEMICAL PHARMACOLOGY

Chemistry and Biology of Fascaplysin, a Potent Marine-Derived CDK-4 Inhibitor

(2012) S. B. Bharate et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling

(2012) Muhammad Imtiaz Shafiq et al.   PLoS One

PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53

(2011) R. Zandi et al.   CLINICAL CANCER RESEARCH

Fascaplysin exert anti-tumor effects through apoptotic and anti-angiogenesis pathways in sarcoma mice model

(2011) Xiaojun Yan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The Cytoprotective Effect of N-acetyl-L-cysteine against ROS-Induced Cytotoxicity Is Independent of Its Ability to Enhance Glutathione Synthesis

(2010) Fengjiao Zhang et al.   TOXICOLOGICAL SCIENCES

Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity

(2009) Y.L. Zheng et al.   BIOMEDICINE & PHARMACOTHERAPY

Achaete-Scute Complex Homologue 1 Regulates Tumor-Initiating Capacity in Human Small Cell Lung Cancer

(2009) T. Jiang et al.   CANCER RESEARCH

Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos

(2009) Yingfei Wang et al.   EXPERIMENTAL NEUROLOGY

Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors

(2008) T. Eltze et al.   MOLECULAR PHARMACOLOGY